col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


32 Results       Page 1

 [1] 
Wiley: Diabetes Obesity and Metabolism
  original article Date Title Authors   All Authors
1 [GO] 2024―Sep―03 Patients with type 1 diabetes are at elevated risk of developing new hypertension, chronic kidney disease and diabetic ketoacidosis after COVID-19: Up to 40 months’ follow-up Shiv Mehrotra-Varma, Justin Y. Lu, Montek Singh Boparai, Sonya Henry, Stephen H. Wang, Tim Q. Duong
2 [GO] 2024―Aug―07 Comparing the effectiveness of molnupiravir and nirmatrelvir-ritonavir in non-hospitalized and hospitalized COVID-19 patients with type 2 diabetes: A target trial emulation study Eric Y. F. Wan, Zoey C. T. Wong, Vincent K. C. Yan, Celine S. L. Chui, Francisco T. T. Lai, Xue Li, et al. (+2)
3 [GO] 2023―Dec―22 Reduced incidence of diabetes during the COVID-19 pandemic in Alberta: A time-segmented longitudinal study of Alberta's Tomorrow Project Ming Ye, Jennifer E. Vena, Grace Shen-Tu, Jeffrey A. Johnson, Dean T. Eurich
4 [GO] 2023―Oct―06 The impact of type 2 diabetes and glycaemic control on mortality and clinical outcomes in hospitalized patients with COVID-19 in the capital region of Denmark Vivian Kliim-Hansen, Karl S. Johansson, Lærke S. Gasbjerg, Espen Jimenez-Solem, Tonny S. Petersen, Martin E. Nyeland, et al. (+6)
5 [GO] 2023―Sep―22 Long-term effects of coronavirus disease 2019 on diabetes complications and mortality in people with diabetes: Two cohorts in the UK and Hong Kong Eric Yuk Fai Wan, Sukriti Mathur, Ran Zhang, Athene Hoi Ying Lam, Boyuan Wang, Vincent Ka Chun Yan, et al. (+8)
6 [GO] 2023―Sep―20 Telehealth use and its impact on clinical outcomes in patients with type 2 diabetes during the COVID-19 pandemic Yixue Shao, Lizheng Shi, Elizabeth Nauman, Eboni Price-Haywood, Charles Stoecker
7 [GO] 2023―Jul―25 Impact of the COVID-19 pandemic on new diagnoses of type 2 diabetes in England Emma Barron, Kamlesh Khunti, Alison K. Wright, Darren M. Ashcroft, Matthew J. Carr, Martin K. Rutter, Jonathan Valabhji
8 [GO] 2023―Jul―03 An update on the incidence of type 1 diabetes during the COVID-19 pandemic years Carlo Bruno Giorda, Roberto Gnavi, Barbara Tartaglino, Lucia Favella, Francesco Romeo, Alessandro Migliardi, et al. (+2)
9 [GO] 2023―Jun―14 Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes Sungho Bea, Ahhyung Choi, Jae Hyeon Kim, Young Min Cho, Won Suk Choi, Jaehun Jung, Ju-Young Shin
10 [GO] 2023―May―31 Surfing the waves of the COVID-19 pandemic with diabetes mellitus: Analysis of changes in the diabetes therapy, metabolism and physical activity of 92 992 people living with type 1 or type 2 diabetes from the German DPV registry Bettina Hartmann, Sascha René Tittel, Anton Gillesen, Barbara Klarl, Florian Kopp, Svenja Meyhöfer, et al. (+4)
11 [GO] 2023―May―31 Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: Comparison with influenza and pre-pandemic data Kevin Dell'Aquila, Jeylin Lee, Stephen H. Wang, Tharun T. Alamuri, Rebecca Jennings, Helen Tang, et al. (+9)
12 [GO] 2023―Feb―22 Trends and Cyclic Variation in the Incidence of Childhood Type 1 Diabetes in Two Italian Regions Over 33 Years and During The Covid-19 Pandemic Rosaria Gesuita, Ivana Rabbone, Vittorio Marconi, Luisa De Sanctis, Monica Marino, Valentina Tiberi, et al. (+6)
13 [GO] 2022―Sep―13 Ethnicity and risks of severe COVID-19 outcomes associated with glucose-lowering medications: a cohort study Francesco Zaccardi, Pui San Tan, Carol Coupland, Baiju R. Shah, Ash Kieran Clift, Defne Saatci, et al. (+5)
14 [GO] 2022―Sep―04 SARS-CoV-2S antibody level decline is more pronounced after second vaccination but response to the third COVID -19 vaccination is similar in people with type 1 and type 2 diabetes compared to healthy controls - the prospective COVAC-DM cohort study Caren Sourij, Faisal Aziz, Harald Kojzar, Anna M Obermayer, Christoph Sternad, Alexander Müller, et al. (+12)
15 [GO] 2022―Sep―03 Clinical significance of pre-diabetes, undiagnosed diabetes, and diagnosed diabetes on clinical outcomes in COVID-19: Integrative analysis from the Japan COVID-19 Task Force Takahiro Fukushima, Shotaro Chubachi, Ho Namkoong, Takanori Asakura, Hiromu Tanaka, Ho Lee, et al. (+466)
16 [GO] 2022―Aug―20 Associations of microvascular complications with all-cause death in patients with diabetes and COVID -19: the CORONADO , ABCD Covid-19 audit and AMERICADO study groups Samy Hadjadj, Pierre-Jean Saulnier, Yue Ruan, Xu Zhu, Renee Pekmezaris, Michel Marre, et al. (+25)
17 [GO] 2022―Aug―16 Are Ambulatory ACE Inhibitors/Angiotensin Receptor Blockers Associated with Reduced SARS-CoV -2 Infections and Improved Outcomes, and Does Race Matter? John Armato, Ralph A DeFronzo, Shih-Ting Chiu, Deanna Rider, Ronald Ruby
18 [GO] 2022―May―31 Glycemic measures for 8,914 adult FreeStyle ® Libre users during routine care, segmented by age group and observed changes during the COVID pandemic Pratik Choudhary, Kalvin Kao, Timothy C. Dunn, Laura Brandner, Gerry Rayman, Emma G Wilmot
19 [GO] 2022―May―23 The impact of the Covid-19 pandemic on glycaemic control in people with diabetes: a systematic review and meta-analysis Lauren L O’Mahoney, Patrick J Highton, Laura Kudlek, Jessica Morgan, Rosie Lynch, Ella Schofield, et al. (+9)
20 [GO] 2022―Apr―04 Association between antidiabetic drug use and the risk of COVID-19 hospitalization in the INSIGHT Clinical Research Network in New York City Jea Young Min, Will Simmons, Samprit Banerjee, Fei Wang, Nicholas Williams, Yongkang Zhang, et al. (+3)
21 [GO] 2022―Mar―16 The benefit of dexamethasone in patients with COVID-19 infection is preserved in patients with diabetes Pei Chia Eng, Walter Distaso, Hashmi Durreshahwar, Yusuf Shaikhali, Divani Narendranathan, Rebecca Cassin-Scott, et al. (+7)
22 [GO] 2022―Jan―05 Humoral immune response to Covid-19 vaccination in diabetes: age-dependent but independent of type of diabetes and glycaemic control - the prospective COVAC-DM cohort study Caren Sourij, Norbert J Tripolt, Faisal Aziz, Felix Aberer, Patrick Forstner, Anna M Obermayer, et al. (+22)
23 [GO] 2021―Feb―19 Meta-analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium-glucose co-transporter-2 inhibitors; implications for COVID19 pandemic. Dimitrios Patoulias, Christodoulos Papadopoulos, Aristi Boulmpou, Michael Doumas
24 [GO] 2021―Jan―27 Comparable COVID -19 outcomes with current use of GLP -1 receptor agonists, DPP -4 inhibitors or SGLT -2 inhibitors among patients with diabetes who tested positive for SARS-CoV -2 Simone Bastrup Israelsen, Anton Pottegård, Håkon Sandholdt, Sten Madsbad, Reimar Wernich Thomsen, Thomas Benfield
25 [GO] 2020―Dec―15 Change in glucose-lowering medication regimen in individuals with type 2 diabetes mellitus during the COVID -19 pandemic in Germany Louis Jacob, Sarah Rickwood, Wolfgang Rathmann, Karel Kostev
26 [GO] 2020―Nov―17 Covid-19 fatality prediction in people with diabetes and prediabetes using a simple score at hospital admission H. Sourij, F. Aziz, A. Bräuer, C Ciardi, M. Clodi, P. Fasching, et al. (+52)
27 [GO] 2020―Sep―01 Effects of Hyperglycaemia on Complications of COVID-19: A Meta-Analysis of Observational Studies Ming Hui Lee, Chloe Wong, Cheng Han Ng, David Chao Wei Yuen, Amanda Yuan Ling Lim, Chin Meng Khoo
28 [GO] 2020―Jul―06 Admission fasting blood glucose predicts 30-day poor outcome in patients hospitalized for COVID-19 pneumonia Bin Zhang, Shuyi Liu, Lu Zhang, Yuhao Dong, Shuixing Zhang
29 [GO] 2020―Jul―06 Diabetes, Obesity and COVID-19: A Complex Interplay PRJ Vas, D Hopkins, MD Feher, F Rubino, MB Martin
30 [GO] 2020―Jun―04 Influence of diabetes mellitus on the severity and fatality of SARS-CoV -2 infection Jing Wu, Jingqi Zhang, Xiaohua Sun, Lijuan Wang, Yunfang Xu, Yuanyuan Zhang, et al. (+2)
31 [GO] 2020―May―14 The Clinical Characteristics and Outcomes of Diabetes Mellitus and Secondary Hyperglycaemia Patients with Coronavirus Disease 2019: a Single-center, Retrospective, Observational Study in Wuhan Yang Zhang, Haichao Li, Jian Zhang, Yedi Cao, Xue Zhao, Nan Yu, et al. (+6)
32 [GO] 2020―Apr―22 Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 ( SARS-CoV -2 or COVID -19) Sachin Khunti, Nitisha Khunti, Samuel Seidu, Kamlesh Khunti
 [1] 

32 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec